Plancorp, LLC Gilead Sciences, Inc. Transaction History

Plancorp, LLC

$2.44 Billion
Q3 2024

A detailed history of Plancorp, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Plancorp, LLC holds 5,904 shares of GILD stock, worth $532,481. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,904

Previous 5,711 3.38%

Holding current value

$532,481

Previous $391,000 26.34%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $12,851 - $16,210	193 Added 3.38%	5,904 $494,000
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $10,167 - $11,733	-161 Reduced 2.74%	5,711 $391,000
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $13,457 - $16,410	188 Added 3.31%	5,872 $430,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $9,525 - $10,801	130 Added 2.34%	5,684 $460,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $22,108 - $24,120	299 Added 5.69%	5,554 $416,000
Q2 2023 Jul 26, 2023	SELL	$76.01 - $86.7 $1,064 - $1,213	-14 Reduced 0.27%	5,255 $405,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $231 - $264	3 Added 0.06%	5,269 $437,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1,371 - $1,968	22 Added 0.42%	5,266 $452,000
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $7,204 - $8,229	121 Added 2.36%	5,244 $324,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $13,621 - $15,342	236 Added 4.83%	5,123 $317,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $20,735 - $25,983	-358 Reduced 6.83%	4,887 $291,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $2,076 - $2,356	32 Added 0.61%	5,245 $381,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $20,713 - $22,347	306 Added 6.24%	5,213 $364,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $25,895 - $28,294	-408 Reduced 7.68%	4,907 $338,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $180 - $205	-3 Reduced 0.06%	5,315 $344,000
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $13,369 - $15,233	236 Added 4.64%	5,318 $310,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $30,925 - $38,883	498 Added 10.86%	5,082 $321,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $20,906 - $24,276	289 Added 6.73%	4,584 $353,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $268,995 - $344,544	4,295 New	4,295 $321,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $1.06 Million - $1.19 Million	-17,181 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $26,637 - $29,841	426 Added 2.54%	17,181 $1.12 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $7,083 - $9,243	-117 Reduced 0.69%	16,755 $1.05 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $1.22 Million - $1.44 Million	16,872	16,872 $1.37 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.

Account